Expand Microtubules Content plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Microtubules are dynamic cytoskeletal polymers essential for cell structure, intracellular transport, and cell division in all eukaryotic cells[1]. In neurons, microtubules are particularly critical for axonal and dendritic transport, synaptic function, neuronal polarity, and overall cell viability[2]. These hollow cylindrical structures are composed of α/β-tubulin heterodimers and exhibit dynamic instability—the constant growth and shrinkage that enables rapid reorganization in response to cellular signals[3].
Dysfunction of microtubules has emerged as a critical contributor to neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS)[4]. Axonal transport deficits resulting from microtubule dysfunction lead to accumulation of proteins and organelles, synaptic loss, and ultimately neuronal death.
Microtubules are hollow cylindrical polymers with a diameter of approximately 25 nm and a lumen diameter of approximately 15 nm:
Multiple tubulin genes encode distinct isotypes with tissue-specific expression and functional specialization[6]:
| Isotype | Genes | Tissue Distribution |
|---|---|---|
| α-Tubulin | TUBA1A, TUBA1B, TUBA3E, TUBA4A, TUBA8 | Ubiquitous, neuron-specific variants |
| β-Tubulin | TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB8 | Tissue-specific isoforms |
| γ-Tubulin | TUBG1, TUBG2 | Centrosome/MTOC |
| δ/ε-Tubulin | TUBD1, TUBD2 | Centrioles |
Microtubules undergo constant assembly and disassembly through a process called dynamic instability[7]:
| Phase | Description |
|---|---|
| Rescue | Transition from shrinkage to growth |
| Catastrophe | Transition from growth to shrinkage |
| Growth rate | ~1 μm/min under physiological conditions |
| Shrinkage rate | ~10-15 μm/min |
This dynamic behavior is regulated by:
Neurons rely on microtubules for long-distance transport of cargo between the cell body and synapses:
Two major motor protein families power axonal transport:
Essential cargo transported along microtubules includes:
Axonal transport dysfunction is an early feature of many neurodegenerative diseases[8]:
In Alzheimer's disease (AD), microtubule dysfunction contributes to axonal transport deficits[9]:
Microtubule alterations in Parkinson's disease (PD) include[11]:
In Huntington's disease (HD), microtubule dysfunction results from[12]:
ALS features microtubule defects including[13]:
Drugs that stabilize microtubules show promise for neurodegenerative diseases[14]:
Targeting kinesin and dynein function:
| Drug/Compound | Mechanism | Development Stage |
|---|---|---|
| Epothilone D | Microtubule stabilization | Clinical trials (AD) |
| Davunetide | Peptide stabilizer | Preclinical |
| TPI-287 | Taxane derivative | Phase I/II (AD) |
| ABT-199 | Kinesin modulator | Preclinical |
MAPs regulate microtubule dynamics and serve as bridges to other cellular structures:
Tau is the most studied MAP in neurodegeneration[16]:
Primarily expressed in dendrites, MAP2 stabilizes dendritic microtubules:
Expand Microtubules Content plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Expand Microtubules Content has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol. 1997;13:83-117. PMID:9442869.
[2] Baas PW, Black MM. Neurofilament proteins are associated with axonal microtubules. Brain Res. 1990;532(1-2):166-170. PMID:2256894.
[3] Mitchison T, Kirschner M. Dynamic instability of microtubule growth. Nature. 1984;312(5991):237-242. PMID:6504158.
[4] Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci. 2007;8(9):663-672. PMID:17616513.
[5] Nogales E, Wolf SG, Downing KH. Structure of the alpha beta tubulin dimer by electron crystallography. Nature. 1998;391(6663):199-203. PMID:9428769.
[6] Luduena RF. A hypothesis on the origin and evolution of tubulin genes. Cell Motil Cytoskeleton. 1998;40(2):121-131. PMID:9671567.
[7] Howard J, Hyman AA. Dynamics and mechanics of the microtubule plus end. Nature. 2003;422(6933):753-758. PMID:12700769.
[8] Roy S, Winton MJ, Black MM, et al. Cytoskeletal defects in neurodegenerative disease. Nat Rev Neurosci. 2005;6(9):703-710. PMID:16121133.
[9] Cash AD, Aliev G, Siedlak SL, et al. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol. 2003;162(5):1623-1627. PMID:12707040.
[10] Mandelkow E, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2014;15(2):95-107. PMID:24439389.
[11] Chung CY, Koprich JB, Siddiqi H, Isacson O. Dynamic changes in microtubule-dependent transport in a mouse model of Parkinson's disease. J Neurosci. 2009;29(11):3507-3517. PMID:19295155.
[12] Gunawardena S, Yang G, Goldstein LS. Huntington's disease: defective neuronal transport in the pathogenesis of axonal pathology. Nat Rev Neurosci. 2003;4(9):720-726. PMID:12951644.
[13] Ferri A, Cozzolino M, Crosiglia C, et al. ALS: from cytoskeletal defects to oxidative stress. Neurochem Res. 2004;29(3):517-525. PMID:15038602.
[14] Brunden KR, Trojanowski JQ, Lee VM. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov. 2009;8(10):783-793. PMID:19723442.
[15] Zhang B, Carroll J, Trojanowski JQ, et al. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, cognitive deficits, and neurotoxicity in a mouse model of Alzheimer's disease. J Neurosci. 2012;32(11):3601-3611. PMID:22423084.
[16] Avila J, Lucas JJ, Perez M, Hernandez F. Role of tau protein in both physiological and pathological conditions. Physiol Rev. 2004;84(2):361-384. PMID:15044677.